Literature DB >> 26522495

The feeding responses evoked by endogenous cholecystokinin are regulated by different gastrointestinal sites.

Martha C Washington1, Kasey Williams1, Ayman I Sayegh2.   

Abstract

The current study tested the hypothesis that cholecystokinin (CCK) A receptor (CCKAR) in areas supplied by the celiac artery (CA), stomach and upper duodenum, and the cranial mesenteric artery (CMA), small and parts of the large intestine, is necessary for reduction of meal size, prolongation of the intermeal interval (time between first and second meal) and increased satiety ratio (intermeal interval/meal size or amount of food consumed during any given unit of time) by the non-nutrient stimulator of endogenous CCK release camostat. Consistent with our previous findings camostat reduced meal size, prolonged the intermeal interval and increased the satiety ratio. Here, we report that blocking CCKAR in the area supplied by the celiac artery attenuated reduction of meal size by camostat more so than the cranial mesenteric artery route. Blocking CCKAR in the area supplied by the cranial mesenteric artery attenuated prolongation of the intermeal interval length and increased satiety ratio by camostat more so than the celiac artery route. Blocking CCKAR in the areas supplied by the femoral artery (control) failed to alter the feeding responses evoked by camostat. These results support the hypothesis that CCKAR in the area supplied by the CA is necessary for reduction of meal size by camostat whereas CCKAR in the area supplied by the CMA is necessary for prolongation of the intermeal interval and increased satiety ratio by this substance. Our results demonstrate that meal size and intermeal interval length by camostat are regulated through different gastrointestinal sites. Published by Elsevier Inc.

Entities:  

Keywords:  CCK; Celiac artery; Cranial mesenteric artery; Femoral artery; Food intake

Mesh:

Substances:

Year:  2015        PMID: 26522495     DOI: 10.1016/j.yhbeh.2015.10.019

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  10 in total

1.  Non-sulfated cholecystokinin-8 increases enteric and hindbrain Fos-like immunoreactivity in male Sprague Dawley rats.

Authors:  Amged I Dafalla; Thaer R Mhalhal; Kenneth Hiscocks; John Heath; Ayman I Sayegh
Journal:  Brain Res       Date:  2018-12-17       Impact factor: 3.252

2.  Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.

Authors:  Kamal Albarazanji; Matthew Jennis; Cassandre R Cavanaugh; Wensheng Lang; Bhanu Singh; James C Lanter; James M Lenhard; Pamela J Hornby
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-28       Impact factor: 4.052

3.  Cholecystokinin-33, but not cholecystokinin-8 shows gastrointestinal site specificity in regulating feeding behaviors in male rats.

Authors:  Martha C Washington; Thaer R Mhalhal; Ayman I Sayegh
Journal:  Horm Behav       Date:  2016-08-04       Impact factor: 3.587

Review 4.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

5.  Roux-en-Y gastric bypass augments the feeding responses evoked by gastrin-releasing peptides.

Authors:  Martha C Washington; Thaer R Mhalhal; Tanisha Johnson-Rouse; Jose Berger; John Heath; Randy Seeley; Ayman I Sayegh
Journal:  J Surg Res       Date:  2016-08-20       Impact factor: 2.192

Review 6.  Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.

Authors:  Laurence J Miller; Aditya J Desai
Journal:  Trends Endocrinol Metab       Date:  2016-05-04       Impact factor: 12.015

7.  Peptide Tyrosine Tyrosine 3-36 Reduces Meal Size and Activates the Enteric Neurons in Male Sprague-Dawley Rats.

Authors:  Kayla D Newman; Thaer R Mhalhal; Martha C Washington; John C Heath; Ayman I Sayegh
Journal:  Dig Dis Sci       Date:  2017-10-13       Impact factor: 3.199

8.  The BB2 receptor antagonist BW2258U89 attenuates the feeding responses evoked by exogenous gastrin releasing peptide-29.

Authors:  Martha C Washington; Thaer R Mhalhal; Ayman I Sayegh
Journal:  Horm Behav       Date:  2016-07-02       Impact factor: 3.587

9.  An Apparently Balanced Complex Chromosome Rearrangement Involving Seven Breaks and Four Chromosomes in a Healthy Female and Segregation/Recombination in Her Affected Son.

Authors:  Ana Eduarda Campos; Carla Rosenberg; Ana Krepischi; Marina França; Vanessa Lopes; Viviane Nakano; Tânia Vertemati; Marcos Cochak; Michele Migliavacca; Fernanda Milanezi; Ana Cristina Sousa; Juliana Silva; Lígia Vieira; Priscilla Monfredini; Ana Carolina Palumbo; Jonathas Fernandes; Eduardo Perrone
Journal:  Mol Syndromol       Date:  2021-07-15

Review 10.  Role of the gut-brain axis in energy and glucose metabolism.

Authors:  Hallie R Wachsmuth; Savanna N Weninger; Frank A Duca
Journal:  Exp Mol Med       Date:  2022-04-26       Impact factor: 12.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.